| Challenge of studies on the development of new zn complexes to treat diabetes mellitus. | |
| | |
MedLine Citation:
|
PMID: 21628979 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
In recent years, people all over the world have suffered from various diseases such as cancer, myocardial infarction, osteoporosis, hypertension, and diabetes mellitus (DM). Especially, DM, well-known as one of lifestyle-related diseases, has been regarded as a serious problem, because it is difficult to fully recover. The number of patients suffering from DM in 2007 was reported to be approximately 200 million people worldwide. However, insulin preparations and synthetic therapeutics, which are clinically used treatment of DM, have been associated with problems such as physical and mental pain due to daily injections and certain severe side effects, respectively. Zn, which is an essential trace element in animals and humans and plays an important role in maintenance of their lives, has been indicated to exhibit insulin-like activity. Since the finding of insulin-like effects of Zn, several Zn complexes have been proposed as a new type of anti-diabetic therapeutics which is differ from existing medicines. In this symposium, we introduce the anti-diabetic effect, complication relieving effect, and action mechanism of bis(2-mercaptopyridine-N-oxidato)Zn complex with Zn(S(2)O(2)) coordination mode. |
| | |
Authors:
|
Yutaka Yoshikawa; Hiromu Sakurai; Hiroyuki Yasui |
Related Documents
:
|
10997689 - Amadori-glycated albumin in diabetic nephropathy: pathophysiologic connections. 3197299 - Stability of serum fructosamine during storage. 16037249 - Tandem mass spectrometry analysis of amadori-glycated phosphatidylethanolamine in human... 20722019 - Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexa... 2443089 - Cord blood screening for haemoglobinopathies in northern nigeria. 6652979 - Micro-chromatographic measurement of hemoglobin a1 in uremia. 9179469 - Lack of association of lipoprotein (a) with coronary heart disease in spaniard type 2 d... 8123879 - A chromogenic assay for coagulation factor vii: analytical performance characteristics ... 2218839 - Results of vein graft reconstruction of the lower extremity in diabetic and nondiabetic... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan Volume: 131 ISSN: 1347-5231 ISO Abbreviation: Yakugaku Zasshi Publication Date: 2011 |
Date Detail:
|
Created Date: 2011-06-01 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0413613 Medline TA: Yakugaku Zasshi Country: Japan |
Other Details:
|
Languages: eng Pagination: 925-30 Citation Subset: IM |
Affiliation:
|
Kyoto Pharmaceutical University. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Challenge of Creating Single-agents for the Treatment of Type 1 and 2 Diabetes by Targeting Retinoid...
Next Document: Education for Six-years Graduate School of Pharmaceutical Sciences: A Case of Tohoku University.